Sylvester Comprehensive Cancer Center, University of Miami, 1120 NW 14th St, Miami, FL, 33136, USA.
Department of Medicine, Miller School of Medicine, University of Miami, 1120 NW 14th St, Miami, FL, 33136, USA.
Nat Commun. 2019 Oct 29;10(1):4925. doi: 10.1038/s41467-019-12735-z.
AML1-ETO (AE) is a fusion transcription factor, generated by the t(8;21) translocation, that functions as a leukemia promoting oncogene. Here, we demonstrate that TATA-Box Binding Protein Associated Factor 1 (TAF1) associates with K43 acetylated AE and this association plays a pivotal role in the proliferation of AE-expressing acute myeloid leukemia (AML) cells. ChIP-sequencing indicates significant overlap of the TAF1 and AE binding sites. Knockdown of TAF1 alters the association of AE with chromatin, affecting of the expression of genes that are activated or repressed by AE. Furthermore, TAF1 is required for leukemic cell self-renewal and its reduction promotes the differentiation and apoptosis of AE+ AML cells, thereby impairing AE driven leukemogenesis. Together, our findings reveal a role of TAF1 in leukemogenesis and identify TAF1 as a potential therapeutic target for AE-expressing leukemia.
AML1-ETO(AE)是一种融合转录因子,由 t(8;21)易位产生,作为一种促进白血病的致癌基因发挥作用。在这里,我们证明 TATA 框结合蛋白相关因子 1(TAF1)与 K43 乙酰化的 AE 结合,这种结合在表达 AE 的急性髓系白血病(AML)细胞的增殖中起着关键作用。ChIP-seq 表明 TAF1 和 AE 结合位点有显著的重叠。TAF1 的敲低改变了 AE 与染色质的结合,影响了 AE 激活或抑制的基因的表达。此外,TAF1 是白血病细胞自我更新所必需的,其减少促进了 AE+AML 细胞的分化和凋亡,从而损害了 AE 驱动的白血病发生。总之,我们的研究结果揭示了 TAF1 在白血病发生中的作用,并确定 TAF1 是表达 AE 的白血病的一个潜在治疗靶点。